Aktis Oncology, Inc. Common stock (NASDAQ: AKTS) last traded at $18.15, up 2.31% on the session. The quote above updates while this page is open; the figures below are drawn from Aktis Oncology, Inc. Common stock’s own filings and are restated only when a new one is published.
Aktis Oncology, Inc. Common stock trades on NASDAQ under the ticker AKTS. Its market capitalisation is $970.05 million.
Valuation measures for Aktis Oncology, Inc. Common stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $970.05M |
|---|---|
| Enterprise value | $960.32M |
| Price / book | 2.00 |
| Beta | 1.52 |
Trailing-twelve-month figures tagged in Aktis Oncology, Inc. Common stock's XBRL filings with the SEC.
| Cash |
|---|
| $82.49M |
Range and volume for AKTS over the past 52 weeks.
| 52-week high | $34.19 |
|---|---|
| 52-week low | $14.72 |
| Volume | 361.0K |
| Average volume | 366.0K |
| Previous close | $17.74 |
Invest a chosen dollar amount in Aktis Oncology, Inc. Common stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell AKTS.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.